Cerezyme

Active Ingredient(s): Imiglucerase
FDA Approved: * May 23, 1994
Pharm Company: * GENZYME
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cerezyme Overview

Imiglucerase is a medication used in the treatment of Gaucher's disease.[2][3] It is a recombinant DNA-produced analogue of the human enzyme β-glucocerebrosidase. Cerezyme is a freeze-dried medicine containing imiglucerase, manufactured by Genzyme Corporation. It is given intravenously after reconstitution as a treatment for Type 1 and Type 3[4] Gaucher's disease. It is available in formulations containing 200 or 400 units per vial. The sp...

Read more Cerezyme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Imiglucerase

Recent Cerezyme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Imiglucerase

Injection: 200 units/vial, 200unit, 400 units/vial, 400unit

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cerezyme: (2 results)

Sorted by National Drug Code

58468-1983 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation
58468-4663 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation

Other drugs which contain Imiglucerase or a similar ingredient: (1 result)

IMIGLUCERASE